Condition
Latent Autoimmune Diabetes in Adults (LADA)
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting1
Not Yet Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07460336Not ApplicableNot Yet RecruitingPrimary
Effects of Cofrogliptin on Beta-Cell Function in LADA Patients
NCT06941675Not ApplicableRecruitingPrimary
Hybrid Closed-Loop System in LADA Patients: A Randomized Trial
NCT00776607Not ApplicableUnknownPrimary
Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
Showing all 3 trials